An analysis based on clinical samples showed that ovarian cancer patients with high expression of CXCR4 were significantly less sensitive to chemotherapy and had a poor prognosis, suggesting that CXCR4 is the key molecules for chemotherapy resistance (Li et al., 2014). The gene discussed is CXCR4; the disease is ovarian cancer.